Neonatal drug withdrawal syndrome Completed Phase 3 Trials for Morphine (DB00295)

Also known as: Drug withdrawal syndrome neonatal / Neonatal Abstinence Syndrome / Neonatal withdrawal symptoms from maternal use of drugs of addiction / Drug withdrawal syndrome in newborn / Withdrawal syndrome neonatal / Neonatal abstinence syndrome (disorder)

IndicationStatusPhase
DBCOND0101857 (Neonatal drug withdrawal syndrome)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02810782How to Treat Opiate Withdrawal in NeonatesTreatment
NCT01958476Improving Outcomes in Neonatal Abstinence SyndromeTreatment
NCT01452789Blinded Trial of Buprenorphine or Morphine in the Treatment of the Neonatal Abstinence SyndromeTreatment